What is the recommended colorectal cancer screening for a male who has never had a colonoscopy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colorectal Cancer Screening Recommendation for Males Without Prior Colonoscopy

Begin colorectal cancer screening at age 45 with either colonoscopy every 10 years or annual fecal immunochemical testing (FIT) as first-tier options. 1, 2

Starting Age for Screening

  • For average-risk males, initiate screening at age 45 years based on updated 2022 U.S. Multi-Society Task Force recommendations that reflect rising colorectal cancer incidence in younger adults 1, 2
  • The recommendation to start at age 45 represents a shift from the previous age 50 threshold, supported by evidence showing similar rates of advanced neoplasia in 45-49 year-olds compared to historical 50-year-old screening cohorts 2
  • For males who have not initiated screening before age 50, screening remains strongly recommended starting at age 50 1

First-Tier Screening Options

Colonoscopy every 10 years and annual FIT are the preferred first-tier screening tests that should be offered as cornerstones of screening regardless of approach 1, 2

Colonoscopy Approach

  • Colonoscopy every 10 years is the preferred cancer prevention test with the advantage of both detecting and removing precancerous lesions during the same procedure 1
  • Quality colonoscopy requires cecal intubation rates exceeding 90%, withdrawal time of at least 6 minutes, and adenoma detection rates of at least 25% in men 2
  • Colonoscopy allows for immediate polypectomy, preventing progression to cancer 1

Annual FIT Approach

  • Annual fecal immunochemical testing (FIT) is equally recommended as a first-tier option for those who prefer non-invasive screening 1, 2
  • FIT must be performed annually to maintain effectiveness 1, 2
  • All positive FIT results require timely follow-up colonoscopy for diagnostic evaluation—this is non-negotiable 2, 3

Second-Tier Screening Options

If the patient declines both colonoscopy and FIT, offer these alternatives:

  • CT colonography every 5 years (strong recommendation despite lower quality evidence) 1
  • Multitarget stool DNA test (FIT-DNA) every 3 years 1, 2
  • Flexible sigmoidoscopy every 5-10 years (can be combined with FIT every 2 years) 1

Risk Stratification Considerations

Average-Risk Males

  • No personal history of colorectal cancer, adenomatous polyps, or inflammatory bowel disease 2
  • No first-degree relatives with colorectal cancer or advanced adenomas 2
  • Follow standard screening starting at age 45 1, 2

Higher-Risk Males Requiring Earlier/More Frequent Screening

Begin colonoscopy at age 40 or 10 years before the youngest affected relative's diagnosis (whichever comes first) and repeat every 5 years if: 1, 2, 4

  • First-degree relative diagnosed with colorectal cancer or advanced adenoma before age 60
  • Two or more first-degree relatives with colorectal cancer or advanced adenomas at any age

Begin colonoscopy at age 40 and repeat every 5 years if: 1

  • Single first-degree relative diagnosed with colorectal cancer or advanced adenoma at age 50-59

When to Stop Screening

  • Discontinue screening at age 75 for males who are up-to-date with prior negative screening tests, particularly if they have had a negative colonoscopy 1, 2
  • Stop screening when life expectancy falls below 10 years regardless of age due to comorbidities 1, 2
  • For males aged 76-85 without prior screening, individualize decisions based on overall health status, comorbidities, and life expectancy 1, 3
  • Discourage screening beyond age 85 as harms outweigh benefits regardless of screening history 2, 3

Tests to Avoid

  • Do not use blood-based tests (including Septin9 serum assay) for colorectal cancer screening as they lack evidence for mortality benefit 1, 3
  • Do not rely on single stool samples obtained during digital rectal examination 1

Sequential Offer Approach

The most practical clinical approach for males who have never been screened:

  1. Offer colonoscopy first as the preferred prevention test 1
  2. If colonoscopy is declined, offer annual FIT as the alternative first-tier option 1
  3. If both are declined, offer second-tier tests (CT colonography, FIT-DNA, or flexible sigmoidoscopy) 1
  4. Ensure follow-up colonoscopy for any positive non-colonoscopy screening test 2, 3

Critical Implementation Points

  • The average time to prevent one colorectal cancer death is 10.3 years from screening initiation, emphasizing the importance of adequate life expectancy 3
  • Quality metrics must be tracked for colonoscopy providers, including adenoma detection rates and cecal intubation rates 2
  • Adequate bowel preparation is paramount for colonoscopy effectiveness 5
  • All positive stool-based tests mandate diagnostic colonoscopy—failure to follow up represents a critical breakdown in the screening process 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Colon Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Colorectal Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Colonoscopy in Colorectal Cancer Screening: Current Aspects.

Indian journal of surgical oncology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.